Files
Download Full Text (2.9 MB)
Description
Psoriasis is a chronic inflammatory skin disease marked by keratinocyte hyperproliferation and immune dysregulation. Verrucous psoriasis, a rare variant, presents with thick, hyperkeratotic, wart-like plaques that are often refractory to standard treatments. Secukinumab, a monoclonal antibody targeting IL-17A, has demonstrated efficacy in plaque psoriasis, but data on its use in verrucous psoriasis is limited. This case highlights complete remission of verrucous psoriasis with secukinumab.
Publication Date
5-9-2024
Disciplines
Dermatology
Recommended Citation
Hansen N, Reed M, Aron J. Verrucous psoriasis treated with secukinumab. Presented at Corewell Health Hospital Farmington Hills 2024 Alvin Yarrows Research Day; 2024 May 9; Farmington Hills, MI.
Comments
2024 Alvin Yarrows Research Day at Corewell Health Hospital Farmington Hills, Farmington Hills, MI, May 9, 2024.